Erscheinung:30.11.2022, Stand:updated on 08.12.2022 | Topic Measures Elanix Biotechnologies AG: BaFin imposes administrative fines
On 17 November 2022, BaFin imposed administrative fines totalling 200,100 euros on Elanix Biotechnologies AG.
The sanction related to breaches of section 114 (1) sentence 2 and section 115 (1) sentence 1 and sentence 2 of the German Securities Trading Act (Wertpapierhandelsgesetz – WpHG) and a breach of section 40 (1) sentence 1 WpHG.
Elanix Biotechnologies AG failed to publish announcements, stating the date and the website on which the accounting documents listed in section 114 (2) of the WpHG for the financial years 2019 and 2020 were made publicly available in addition to their availability in the Company Register (Unternehmensregister).
Elanix Biotechnologies AG failed to make its half-yearly financial reports for the financial years 2020 and 2021 publicly available.
Elanix Biotechnologies AG failed to publish announcements, stating the date and the website on which the half-yearly financial reports for the financial years 2020 and 2021 were made publicly available in addition to its availability in the Company Register.
Elanix Biotechnologies AG failed to publish a voting right notification within the prescribed period.
The company may lodge an appeal against the administrative fine order.
Update (08.12.2022):
On 1 December 2022, the company lodged an appeal against the administrative fine order.
